In this work, we present an ew synthetics trategy for fourfold-substituted perylene monoimides via tetrabrominated perylene monoanhydrides. X-ray diffraction analysis unveiled the intramolecular stacking orientation between the substituents and semicircular packing behavior.W eo bserved the remarkable influence of the substituent on the longevity and nature of the excited state upon visible light excitation.I nt he presenceo fp oly(dehydroalanine)-graftpoly(ethylene glycol)g raft copolymers as solubilizing template, the chromophores are capable of sensitizing [Mo 3 S 13 ] 2À clustersi na queous solution for stable visible light driven hydrogen evolution over three days.
The photochemistry of Ru coordination compounds is generally discussed to originate from the lowest lying triplet metal-to-ligand charge-transfer state ( MLCT). However, when heteroleptic complexes are considered, for example, in the design of molecular triads for efficient photoinduced charge separation, a complex structure of MLCT states, which can be populated in a rather narrow spectral window (typically around 450 nm) is to be considered. In this contribution we show that the localization of MLCT excited states on different ligands can affect the following ps to ns decay pathways to an extent that by tuning the excitation wavelength, intermolecular energy transfer from a Ru -terpyridine unit to a fullerene acceptor can be favored over electron transfer within the molecular triad. These results might have important implications for the design of molecular dyads, triads, pentads and so forth with respect to a specifically targeted response of these complexes to photoexcitation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.